Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers.

Ramaswamy, Anant; Ostwal, Vikas; Gupta, Kushal; Simha, Vijai; Toshniwal, Anup; Shetty, Nitin; Nashikkar, Chaitali; Mandavkar, Sarika; Gupta, Sudeep.

Affiliation

Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Ostwal V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Gupta K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Simha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Toshniwal A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Shetty N; Department of Radiology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Nashikkar C; Department of GIDMG, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Mandavkar S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Gupta S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.